Despite their importance, bioassays have limitations. In vivo assays pose ethical challenges and may not perfectly translate to human outcomes. In vitro assays, while efficient, may oversimplify interactions that occur in living organisms. In silico models depend on the quality of existing data and may not account for novel interactions or chemicals. Thus, a combination of methods is often necessary for a comprehensive assessment.
